SCHEMBL26545921

SCHEMBL26545921

Cc1cc(NC(=O)C(Cc2ccccc2)C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(C(F)(F)F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 2/20 0.55
▸ TP53 P04637 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ TAS2R14 Q9NYV8 1/20 0.50
▸ ACP1 P24666 1/20 0.50
▸ PTPN7 P35236 1/20 0.50
▸ PTPN12 Q05209 1/20 0.50
▸ PTPN13 Q12923 1/20 0.50
▸ SSU72 Q9NP77 1/20 0.50
▸ P2RX1 P51575 5/20 0.49
▸ MAPT P10636 2/20 0.47
▸ POLB P06746 2/20 0.47
▸ MYC P01106 1/20 0.47
▸ MAX P61244 1/20 0.47
▸ TMPRSS4 Q9NRS4 1/20 0.46
▸ P2RX4 Q99571 1/20 0.46
▸ P2RX7 Q99572 1/20 0.46
▸ TRPA1 O75762 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11306381 0.92 TACR1 (0.63) TACR1TP53ALDH1A1ACP1PTPN7
SCHEMBL3277359 0.80 TACR1 (0.60) TACR1TP53ACP1PTPN7PTPN12
SCHEMBL3277354 0.80 TACR1 (0.60) TACR1TP53ACP1PTPN7PTPN12
SCHEMBL26623692 0.76 MAPT (0.54) TACR1ALDH1A1TAS2R14ACP1PTPN7
SCHEMBL25777244 0.75 P2RX1 (0.80) TAS2R14P2RX1MAPTTMPRSS4P2RX4
SCHEMBL11315808 0.74 MAPT (0.48) TP53ALDH1A1MAPTPOLBTMPRSS4
SCHEMBL12172752 0.74 TAS2R14 (0.68) ALDH1A1TAS2R14P2RX1TMPRSS4P2RX4
SCHEMBL14791167 0.74 HTT (0.53) TACR1ALDH1A1TAS2R14ACP1PTPN7
SCHEMBL14853314 0.73 HDAC1 (0.61) TP53ALDH1A1MAPTPOLBMEN1
SCHEMBL26623574 0.73 P2RX1 (0.67) TP53ALDH1A1TAS2R14P2RX1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230330061-A1 ANTIMICROBIAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF NATIONAL TAIWAN UNIVERSITY (TW) 2023-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230330061-A1 ANTIMICROBIAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FASN, NAAA, FPR3 TACR1 2003/4885TP53 3833/4885ALDH1A1 1883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback